You are here

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Kingston, Ontario, K7L 2V7 Canada
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Allergic Rhinitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-60 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female subjects 18-60 years allergic to ragweed pollen.

- Subjects with appropriate symptom scores following exposure to ragweed in the
environmental exposure unit.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with significant diseases other than allergic rhinitis that may interfere
with the safety or efficacy of PF-03654764.

- Subjects with significant symptoms of allergic rhinitis within the 2 weeks prior to
screening.

NCT01033396
Pfizer
Completed
The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now